Agonist-specific down-regulation of the human δ-opioid receptor

European Journal of Pharmacology

Volumn 459, Issue 1, 2003, Pages 9-16

  Okura, Takashi ^a   Varga, Eva V ^a,b   Hosohata, Yoshiaki ^a   Navratilova, Edita ^a   Cowell, Scott M ^a   Rice, Kenner ^c   Nagase, Hiroshi ^d   Hruby, Victor J ^a   Roeske, William R ^a,b   Yamamura, Henry I ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d TORAY INDUSTRIES INC   (Japan)

Author keywords

Opioid receptor; Agonist directed trafficking; Down regulation; Human; Pertussis toxin; Phosphorylation

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ANTIBODY; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MEMBRANE RECEPTOR; NALTRINDOLE; PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL STRAIN; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENKEPHALIN, D-PENICILLAMINE (2,5)-; HUMANS; MOLECULAR SEQUENCE DATA; NALTREXONE; PERTUSSIS TOXIN; PHOSPHORYLATION; PIPERAZINES; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, DELTA; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; TRITIUM;

EID: 12244252751     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02823-6     Document Type: Article

References (33)

1. Allouche S., Roussel M., Marie N., Zaujac P. Differential desensitization of human δ-opioid receptors by peptide and alkaloid agonists. Eur. J. Pharmacol. 37:1999;235-240.
2. Arden J.R., Segredo V., Wang Z., Lameh J., Sadee W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65:1995;1636-1645.
3. Bohm S.K., Grady E.F., Bunett N.W. Regulatory mechanisms that modulate signaling by G protein-coupled receptors. Biochem. J. 322:1997;1-18.
4. Bot G., Blake A.D., Li S., Reisine T. Fentanyl and its analogs desensitize the cloned mu opioid receptor. J. Pharmacol. Exp. Ther. 285:1998;1207-1218.
5. Calderon S.N., Rice K.C., Rothman R.B., Porreca F., Flippen-Anderson J.L., Kayakiri H., Xu H., Becketts K., Smith L.E., Bilsky E.J., Davis P., Horvath R. Probes for narcotic receptor mediated phenomena: 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands. J. Med. Chem. 40:1997;695-704.
6. Chakrabarti S., Yang W., Law P.-Y., Loh H.H. The μ-opioid receptor down-regulates differently from the δ-opioid receptor: requirement of a high affinity receptor/G protein complex formation. Mol. Pharmacol. 52:1997;105-113.
7. 353, located within the COOH-terminal tail of the δ opiate receptor, is involved in receptor down-regulation. J. Biol. Chem. 271:1996;4073-4076.
8. Hosohata Y., Varga E.V., Stropova D., Li X., Knapp R.J., Hruby V.J., Rice K.C., Nagase H., Roeske W.R., Yamamura H.I. Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activation. Life Sci. 68:2001;2233-2242.
9. Keith D.E., Anton B., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Montelet-Agius C., Stewart P.L., Evans C.J., von Zastrow M. μ-opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in mammalian brain. Mol. Pharmacol. 53:1998;377-384.
10. Knapp R.J., Malatynska E., Fang L., Li X., Babin E., Nguyen M., Santoro G., Varga E.V., Hruby V.J., Roeske W.R., Yamamura H.I. Identification of a human delta opioid receptor: cloning and expression. Life Sci. 54:1994;PL463-PL469.
11. Kramer H.K., Andria M.L., Esposito D.H., Simon E.J. Tyrosine phosphorylation of the δ-opioid receptor. Biochem. Pharmacol. 60:2000;781-792.
12. Law P.-Y., Louie A.K., Loh H.H. Effect of pertussis-toxin treatment on the down-regulation of opiate receptors in neuroblastoma×glioma NG108-15 hybrid cells. J. Biol. Chem. 260:1985;14818-14824.
13. 284 of the human δ opioid receptor is required for SNC121 binding but not binding of pCl-DPDPE, deltophin II or naltrindole. Analgesia. 1:1995;539-542.
14. Li J.-G., Luo L.-Y., Krupnick J.G., Benovic J.L., Lu-Chen L.-Y. U 50,488-induced internalization of the human κ opioid receptor involves a β-arrestin- and dynamin-dependent mechanism. J. Biol. Chem. 274:1999;12087-12094.
15. Lowe J.D., Celver J.P., Gurevich V.V., Chavkin C. Mu-opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin. J. Biol. Chem. 277:2002;15729-15735.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Maestri-El Kouhen O., Wang G., Solberg J., Erickson L.J., Law P.-Y., Loh H.H. Hierarchical phosphorylation of δ-opioid receptor regulates agonist-induced receptor desensitization and internalization. J. Biol. Chem. 275:2000;36659-36664.
18. Malatynska E., Wang Y., Knapp R.J., Waite S., Calderon S., Rice K., Hruby V.J., Yamamura H.I., Roeske W.R. Human delta opioid receptor: functional studies on stably transfected CHO cells following acute and chronic treatment with the selective non-peptidic agonist SNC-80. J. Pharmacol. Exp. Ther. 278:1996;1083-1089.
19. Murray S.R., Evans C.J., von Zastrow M. Phosphorylation is not required for dynamin-dependent endocytosis of a truncated mutant opioid receptor. J. Biol. Chem. 273:1998;24987-24991.
20. Nagase H., Kawai K., Hayakawa J., Wakita H., Mizusura A., Matsura H., Tajima C., Takezawa Y., Endoh T. Rational drug design and synthesis of highly selective nonpeptide δ-opioid agonist, (4aS*,12aR*)-4a-3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a- octahydropyridol-{3,4-b]acridine (TAN 67). Chem. Pharm. Bull. 46:1998;1695-1702.
21. Okura T., Cowell S.M., Varga E.V., Burkey T.H., Roeske W.R., Hruby V.J., Yamamura H.I. Differential down-regulation of the human delta-opioid receptor by SNC80 and [D-Pen(2),D-Pen(5)]enkephalin. Eur. J. Pharmacol. 387:2000;R11-R13.
22. Quock R.M., Burkey T.H., Varga E.V., Hosohata Y., Hosohata K., Cowell S.M., Slate C.A., Ehlert F.J., Roeske W.R., Yamamura H.I. The δ-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol. Rev. 51:1999;503-532.
23. Rapaka R.S., Porreca F. Development of delta opioid peptides as nonaddicting analgesics. Pharm. Res. 8:1991;1-8.
24. Remmers A.E., Clark M.J., Liu X.Y., Medzihradsky F. Delta opioid receptor down-regulation is independent of functional G protein, yet is dependent on agonist efficacy. J. Pharmacol. Exp. Ther. 287:1998;625-632.
25. Sternini C., Spann M., Anton B., Keith D.E.J., Bunnett N.W., von Zastrow M., Evans C.J., Brocha N.C. Agonist selective endocytosis of μ-opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9241-9246.
26. Tao P.L., Chang L.R., Law P.-Y., Loh H.H. Decrease in delta-opioid receptor density in rat brain after chronic DADLE treatment. Brain Res. 462:1988;313-319.
27. 5]enkephalin analogues with increased affinity and selectivity for delta opioid receptors. J. Med. Chem. 33:1990;249-253.
28. Trapaidze N., Keith D.E., Cvejic S., Evans C.J., Devi L.A. Sequestration of the δ-opioid receptor, role of the C terminus in agonist-mediated internalization. J. Biol. Chem. 271:1996;29279-29285.
29. Whistler J., von Zastrow M. Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transduction. J. Biol. Chem. 274:1999;24575-24578.
30. Zaki P.A., Keith D.E., Thomas J.B., Carroll F.I., Evans C.J. Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activation. J. Pharmacol. Exp. Ther. 298:2001;1015-1020.
31. Zhang J., Ferguson S.S., Law P.-Y., Barak L.S., Caron M.G. Agonist-specific regulation of delta-opioid receptor trafficking by G protein coupled receptor kinase and beta-arrestin. J. Recept. Signal Transduct. Res. 19:1999;301-313.
32. 4]deltorphin II on tolerance to their analgesic action and on brain δ-opioid receptors. Brain Res. 745:1997;243-247.
33. Zhao J., Pei G., Huang Y., Zhong F., Ma L. Carboxyl terminus of delta opioid receptor is required for agonist-dependent receptor phosphorylation. Biochem. Biophys. Res. Commun. 238:1997;71-76.